A Phase II Trial Of Imatinib Mesylate (Gleevec) In Patients With HIV Related Kaposi's Sarcoma.
Phase of Trial: Phase II
Latest Information Update: 08 Mar 2018
At a glance
- Drugs Imatinib (Primary)
- Indications Kaposi's sarcoma
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 17 Dec 2009 Actual end date (Dec 2009) added as reported by ClinicalTrials.gov.
- 15 Dec 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.